CircodeBio (环码生物)

CircodeBio (环码生物) is a biotech company in Shanghai, China, founded in 2021. It has raised $20.0M across 2 rounds, most recently a Series A in August 2023.

环码生物CirCode

Headquarters
Shanghai
Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$20.0M
Last Round
Series AAug 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Shanghai CirCode Biomed Co., Ltd (CirCode, 环码生物) is an innovative biotechnology company specializing in the development of circular RNA (circRNA) therapeutics. Unlike linear mRNA, circular RNA is more stable and less immunogenic, giving it advantages across a broader range of therapeutic applications. CirCode has developed proprietary platform technologies for circular RNA drug development and holds multiple patent families covering this novel technology, with pending applications worldwide. The company is committed to advancing scientific and technological achievements to realize the benefits of circular RNA science for patients. CirCode's pipeline targets disease areas where the enhanced stability and reduced immunogenicity of circular RNA provide meaningful advantages over existing nucleic acid therapies.

Summary

It lists 51–200 employees. It has raised $20.0M in total across 2 rounds, most recently a Series A round in Aug 2023. Investors include Johnson & Johnson Innovation, K2 Venture Capital and Superstring Capital.

Funding History

Data from Indexed.vcUpdated
Series ASeries AAug 2023

Sign up to see all 2 events

Funding: Pre-Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CircodeBio (环码生物) on Indexed.vc
<a href="https://indexed.vc/companies/circodebio"><img src="https://indexed.vc/api/badge/company/circodebio" alt="CircodeBio (环码生物) on Indexed.vc" width="260" height="76" /></a>